Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 2.355.
Step length converged once. Increasing MCMC sample size.
Iteration 2 of at most 500:
Optimizing with step length 0.959522170950488.
The log-likelihood improved by 3.848.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.07647.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.7791.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       31     1228     1039      749      337      383      398 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     300      212      143       96       36       26       11        5 
degree16 degree18 
       3        2 
1 
disease_progression 
H-positive risk:  844 923 146 837 446 130 882 434 112 61 125 60 
H-negative risk:  923 844 882 837 434 446 130 146 125 112 60 61 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
2 
disease_progression 
H-positive risk:  853 924 146 837 440 128 879 435 111 64 125 58 
H-negative risk:  924 853 879 837 435 440 128 146 125 111 58 64 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 1 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
3 
disease_progression 
H-positive risk:  859 924 143 836 439 128 876 433 114 65 125 58 
H-negative risk:  924 859 876 836 433 439 128 143 125 114 58 65 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
4 
disease_progression 
H-positive risk:  859 936 146 835 433 128 882 424 114 62 125 56 
H-negative risk:  936 859 882 835 424 433 128 146 125 114 56 62 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
5 
disease_progression 
H-positive risk:  867 940 147 833 428 128 884 418 116 62 124 53 
H-negative risk:  940 867 884 833 418 428 128 147 124 116 53 62 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
47 new agents 
6 
disease_progression 
H-positive risk:  870 940 147 834 425 127 888 414 116 63 124 52 
H-negative risk:  940 870 888 834 414 425 127 147 124 116 52 63 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
7 
disease_progression 
H-positive risk:  868 944 147 836 422 128 886 414 114 60 127 54 
H-negative risk:  944 868 886 836 414 422 128 147 127 114 54 60 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
50 new agents 
8 
disease_progression 
H-positive risk:  867 945 150 834 429 129 891 403 112 60 127 53 
H-negative risk:  945 867 891 834 403 429 129 150 127 112 53 60 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
73 new agents 
9 
disease_progression 
H-positive risk:  870 951 149 832 428 129 893 400 111 57 127 53 
H-negative risk:  951 870 893 832 400 428 129 149 127 111 53 57 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 13 2 

clinical_engagement 
diagnosis 
demography 
68 new agents 
10 
disease_progression 
H-positive risk:  874 954 149 835 425 127 893 400 107 56 127 53 
H-negative risk:  954 874 893 835 400 425 127 149 127 107 53 56 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
74 new agents 
11 
disease_progression 
H-positive risk:  881 957 150 838 413 128 890 403 106 53 128 53 
H-negative risk:  957 881 890 838 403 413 128 150 128 106 53 53 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 17 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
12 
disease_progression 
H-positive risk:  888 962 150 833 410 129 892 393 108 54 128 53 
H-negative risk:  962 888 892 833 393 410 129 150 128 108 53 54 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 20 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
13 
disease_progression 
H-positive risk:  806 865 139 929 406 122 975 390 120 53 141 54 
H-negative risk:  865 806 975 929 390 406 122 139 141 120 54 53 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 22 3 

clinical_engagement 
diagnosis 
demography 
202 new agents 
14 
disease_progression 
H-positive risk:  840 892 143 891 436 126 916 402 113 50 133 58 
H-negative risk:  892 840 916 891 402 436 126 143 133 113 58 50 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 25 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
15 
disease_progression 
H-positive risk:  846 889 143 895 431 127 917 400 113 48 134 57 
H-negative risk:  889 846 917 895 400 431 127 143 134 113 57 48 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 24 6 

clinical_engagement 
diagnosis 
demography 
76 new agents 
16 
disease_progression 
H-positive risk:  860 895 142 893 421 128 910 398 113 48 137 55 
H-negative risk:  895 860 910 893 398 421 128 142 137 113 55 48 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 27 6 

clinical_engagement 
diagnosis 
demography 
75 new agents 
17 
disease_progression 
H-positive risk:  862 893 143 888 425 125 926 393 111 47 133 54 
H-negative risk:  893 862 926 888 393 425 125 143 133 111 54 47 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 30 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
18 
disease_progression 
H-positive risk:  865 903 143 887 417 126 918 392 110 49 135 55 
H-negative risk:  903 865 918 887 392 417 126 143 135 110 55 49 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 29 5 

clinical_engagement 
diagnosis 
demography 
62 new agents 
19 
disease_progression 
H-positive risk:  870 907 141 884 417 127 917 388 113 48 134 54 
H-negative risk:  907 870 917 884 388 417 127 141 134 113 54 48 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 30 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
20 
disease_progression 
H-positive risk:  877 906 142 879 416 128 919 383 116 46 132 56 
H-negative risk:  906 877 919 879 383 416 128 142 132 116 56 46 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 34 5 

clinical_engagement 
diagnosis 
demography 
73 new agents 
21 
disease_progression 
H-positive risk:  883 912 142 878 413 129 916 381 116 45 130 55 
H-negative risk:  912 883 916 878 381 413 129 142 130 116 55 45 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 36 5 

clinical_engagement 
diagnosis 
demography 
52 new agents 
22 
disease_progression 
H-positive risk:  885 917 144 878 410 127 912 381 115 46 130 55 
H-negative risk:  917 885 912 878 381 410 127 144 130 115 55 46 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 34 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
23 
disease_progression 
H-positive risk:  892 920 141 876 406 127 908 382 118 46 130 54 
H-negative risk:  920 892 908 876 382 406 127 141 130 118 54 46 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 34 9 

clinical_engagement 
diagnosis 
demography 
66 new agents 
24 
disease_progression 
H-positive risk:  898 924 141 876 406 133 906 369 117 46 130 54 
H-negative risk:  924 898 906 876 369 406 133 141 130 117 54 46 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 34 10 

clinical_engagement 
diagnosis 
demography 
60 new agents 
25 
disease_progression 
H-positive risk:  843 860 133 950 404 124 954 368 127 44 138 55 
H-negative risk:  860 843 954 950 368 404 124 133 138 127 55 44 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 38 10 

clinical_engagement 
diagnosis 
demography 
186 new agents 
26 
disease_progression 
H-positive risk:  865 882 134 915 416 126 922 382 123 48 130 57 
H-negative risk:  882 865 922 915 382 416 126 134 130 123 57 48 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 41 10 

clinical_engagement 
diagnosis 
demography 
73 new agents 
27 
disease_progression 
H-positive risk:  873 879 132 912 423 125 915 381 124 49 130 57 
H-negative risk:  879 873 915 912 381 423 125 132 130 124 57 49 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 42 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
28 
disease_progression 
H-positive risk:  883 884 131 911 424 122 907 379 122 51 129 57 
H-negative risk:  884 883 907 911 379 424 122 131 129 122 57 51 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 45 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  888 884 133 914 413 122 913 373 124 50 129 57 
H-negative risk:  884 888 913 914 373 413 122 133 129 124 57 50 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 46 12 

clinical_engagement 
diagnosis 
demography 
54 new agents 
30 
disease_progression 
H-positive risk:  891 888 132 917 412 124 906 373 124 49 130 54 
H-negative risk:  888 891 906 917 373 412 124 132 130 124 54 49 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 47 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
31 
disease_progression 
H-positive risk:  898 894 135 919 405 122 901 372 123 50 134 47 
H-negative risk:  894 898 901 919 372 405 122 135 134 123 47 50 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 49 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
32 
disease_progression 
H-positive risk:  898 902 136 915 399 123 898 373 125 50 134 47 
H-negative risk:  902 898 898 915 373 399 123 136 134 125 47 50 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 50 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
33 
disease_progression 
H-positive risk:  895 905 134 922 400 124 894 370 127 48 135 46 
H-negative risk:  905 895 894 922 370 400 124 134 135 127 46 48 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 49 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
34 
disease_progression 
H-positive risk:  899 903 135 926 392 125 896 364 126 48 139 47 
H-negative risk:  903 899 896 926 364 392 125 135 139 126 47 48 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
35 
disease_progression 
H-positive risk:  903 910 135 922 388 127 899 362 128 42 139 45 
H-negative risk:  910 903 899 922 362 388 127 135 139 128 45 42 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 52 11 

clinical_engagement 
diagnosis 
demography 
64 new agents 
36 
disease_progression 
H-positive risk:  908 908 136 920 382 127 902 366 123 43 139 46 
H-negative risk:  908 908 902 920 366 382 127 136 139 123 46 43 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 51 10 

clinical_engagement 
diagnosis 
demography 
59 new agents 
37 
disease_progression 
H-positive risk:  844 842 124 985 387 125 970 361 122 44 150 46 
H-negative risk:  842 844 970 985 361 387 125 124 150 122 46 44 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 50 11 

clinical_engagement 
diagnosis 
demography 
155 new agents 
38 
disease_progression 
H-positive risk:  856 852 125 956 398 127 953 371 117 50 144 51 
H-negative risk:  852 856 953 956 371 398 127 125 144 117 51 50 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
39 
disease_progression 
H-positive risk:  869 862 125 938 399 131 946 375 115 48 143 49 
H-negative risk:  862 869 946 938 375 399 131 125 143 115 49 48 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 52 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
40 
disease_progression 
H-positive risk:  872 861 127 936 404 131 938 378 114 48 141 50 
H-negative risk:  861 872 938 936 378 404 131 127 141 114 50 48 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 54 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
41 
disease_progression 
H-positive risk:  878 857 127 933 399 132 941 374 117 49 143 50 
H-negative risk:  857 878 941 933 374 399 132 127 143 117 50 49 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 55 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
42 
disease_progression 
H-positive risk:  882 863 128 933 393 134 936 373 111 52 146 49 
H-negative risk:  863 882 936 933 373 393 134 128 146 111 49 52 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 57 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
43 
disease_progression 
H-positive risk:  892 872 128 917 398 136 937 369 112 50 142 47 
H-negative risk:  872 892 937 917 369 398 136 128 142 112 47 50 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 56 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
44 
disease_progression 
H-positive risk:  899 871 127 922 389 136 932 369 114 51 141 49 
H-negative risk:  871 899 932 922 369 389 136 127 141 114 49 51 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 58 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
45 
disease_progression 
H-positive risk:  898 877 127 914 388 138 933 369 114 49 142 51 
H-negative risk:  877 898 933 914 369 388 138 127 142 114 51 49 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
46 
disease_progression 
H-positive risk:  899 885 127 916 386 139 931 362 115 50 142 48 
H-negative risk:  885 899 931 916 362 386 139 127 142 115 48 50 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 60 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  902 880 127 919 391 143 931 354 113 49 142 49 
H-negative risk:  880 902 931 919 354 391 143 127 142 113 49 49 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  904 882 130 917 385 139 935 351 116 47 144 50 
H-negative risk:  882 904 935 917 351 385 139 130 144 116 50 47 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
49 
disease_progression 
H-positive risk:  856 815 121 983 380 125 985 357 129 47 153 49 
H-negative risk:  815 856 985 983 357 380 125 121 153 129 49 47 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
114 new agents 
50 
disease_progression 
H-positive risk:  867 827 123 955 391 124 955 383 129 46 153 47 
H-negative risk:  827 867 955 955 383 391 124 123 153 129 47 46 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
51 
disease_progression 
H-positive risk:  862 832 126 944 393 125 963 380 130 46 150 49 
H-negative risk:  832 862 963 944 380 393 125 126 150 130 49 46 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
52 
disease_progression 
H-positive risk:  852 833 128 948 387 125 970 383 124 50 151 49 
H-negative risk:  833 852 970 948 383 387 125 128 151 124 49 50 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
50 new agents 
53 
disease_progression 
H-positive risk:  852 836 130 946 378 127 974 389 118 52 149 49 
H-negative risk:  836 852 974 946 389 378 127 130 149 118 49 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
54 
disease_progression 
H-positive risk:  850 840 131 951 372 124 979 386 118 51 147 51 
H-negative risk:  840 850 979 951 386 372 124 131 147 118 51 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
57 new agents 
55 
disease_progression 
H-positive risk:  852 832 132 954 373 124 978 387 118 50 146 54 
H-negative risk:  832 852 978 954 387 373 124 132 146 118 54 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
56 
disease_progression 
H-positive risk:  852 839 133 961 366 124 978 384 118 47 143 55 
H-negative risk:  839 852 978 961 384 366 124 133 143 118 55 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
57 
disease_progression 
H-positive risk:  855 842 133 964 362 126 972 379 121 44 145 57 
H-negative risk:  842 855 972 964 379 362 126 133 145 121 57 44 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
58 
disease_progression 
H-positive risk:  848 845 135 965 366 127 969 375 123 43 145 59 
H-negative risk:  845 848 969 965 375 366 127 135 145 123 59 43 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
59 
disease_progression 
H-positive risk:  849 845 132 966 370 128 965 374 122 40 148 61 
H-negative risk:  845 849 965 966 374 370 128 132 148 122 61 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
60 
disease_progression 
H-positive risk:  851 845 130 973 364 127 966 374 123 39 148 60 
H-negative risk:  845 851 966 973 374 364 127 130 148 123 60 39 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
61 
disease_progression 
H-positive risk:  803 798 123 1021 358 114 1024 371 132 41 155 60 
H-negative risk:  798 803 1024 1021 371 358 114 123 155 132 60 41 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
110 new agents 
62 
disease_progression 
H-positive risk:  800 799 122 1015 370 114 994 406 128 41 152 59 
H-negative risk:  799 800 994 1015 406 370 114 122 152 128 59 41 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
63 
disease_progression 
H-positive risk:  802 810 122 1014 366 117 992 398 124 45 149 61 
H-negative risk:  810 802 992 1014 398 366 117 122 149 124 61 45 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
64 
disease_progression 
H-positive risk:  809 812 123 1015 358 115 982 399 126 47 152 62 
H-negative risk:  812 809 982 1015 399 358 115 123 152 126 62 47 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
65 
disease_progression 
H-positive risk:  810 815 127 1015 357 113 984 393 126 47 153 60 
H-negative risk:  815 810 984 1015 393 357 113 127 153 126 60 47 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
66 
disease_progression 
H-positive risk:  814 819 127 1015 351 113 987 389 124 48 155 58 
H-negative risk:  819 814 987 1015 389 351 113 127 155 124 58 48 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 67 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
67 
disease_progression 
H-positive risk:  814 821 128 1010 351 114 986 391 124 45 155 61 
H-negative risk:  821 814 986 1010 391 351 114 128 155 124 61 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
68 
disease_progression 
H-positive risk:  812 821 128 1008 356 115 986 389 126 43 158 58 
H-negative risk:  821 812 986 1008 389 356 115 128 158 126 58 43 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
69 
disease_progression 
H-positive risk:  814 829 128 1012 354 114 984 380 129 43 156 57 
H-negative risk:  829 814 984 1012 380 354 114 128 156 129 57 43 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
70 
disease_progression 
H-positive risk:  821 829 129 1010 351 116 993 370 126 42 155 58 
H-negative risk:  829 821 993 1010 370 351 116 129 155 126 58 42 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
71 
disease_progression 
H-positive risk:  818 840 128 1003 348 115 1000 366 129 44 152 57 
H-negative risk:  840 818 1000 1003 366 348 115 128 152 129 57 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
72 
disease_progression 
H-positive risk:  824 842 126 1002 357 115 998 356 127 45 152 56 
H-negative risk:  842 824 998 1002 356 357 115 126 152 127 56 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
73 
disease_progression 
H-positive risk:  778 790 117 1052 346 109 1054 357 136 45 164 52 
H-negative risk:  790 778 1054 1052 357 346 109 117 164 136 52 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
121 new agents 
74 
disease_progression 
H-positive risk:  779 791 121 1034 359 111 1043 365 131 53 160 53 
H-negative risk:  791 779 1043 1034 365 359 111 121 160 131 53 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
75 
disease_progression 
H-positive risk:  781 791 125 1032 360 114 1039 364 132 50 159 53 
H-negative risk:  791 781 1039 1032 364 360 114 125 159 132 53 50 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
76 
disease_progression 
H-positive risk:  774 794 124 1032 361 115 1045 364 130 50 159 52 
H-negative risk:  794 774 1045 1032 364 361 115 124 159 130 52 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
77 
disease_progression 
H-positive risk:  774 798 126 1030 355 116 1052 359 130 48 160 52 
H-negative risk:  798 774 1052 1030 359 355 116 126 160 130 52 48 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
78 
disease_progression 
H-positive risk:  779 800 125 1038 342 119 1048 355 132 51 158 53 
H-negative risk:  800 779 1048 1038 355 342 119 125 158 132 53 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
53 new agents 
79 
disease_progression 
H-positive risk:  784 805 125 1043 343 120 1035 352 129 53 159 52 
H-negative risk:  805 784 1035 1043 352 343 120 125 159 129 52 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
80 
disease_progression 
H-positive risk:  795 807 127 1046 339 120 1021 353 125 56 158 53 
H-negative risk:  807 795 1021 1046 353 339 120 127 158 125 53 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
81 
disease_progression 
H-positive risk:  791 805 130 1053 339 120 1022 351 124 56 156 53 
H-negative risk:  805 791 1022 1053 351 339 120 130 156 124 53 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
82 
disease_progression 
H-positive risk:  781 797 127 1065 340 120 1028 349 122 59 158 54 
H-negative risk:  797 781 1028 1065 349 340 120 127 158 122 54 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
83 
disease_progression 
H-positive risk:  779 795 128 1064 336 121 1035 344 125 58 158 57 
H-negative risk:  795 779 1035 1064 344 336 121 128 158 125 57 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
84 
disease_progression 
H-positive risk:  778 798 129 1067 333 121 1038 342 122 56 159 57 
H-negative risk:  798 778 1038 1067 342 333 121 129 159 122 57 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
85 
disease_progression 
H-positive risk:  729 759 119 1109 339 112 1076 344 132 56 169 56 
H-negative risk:  759 729 1076 1109 344 339 112 119 169 132 56 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
101 new agents 
86 
disease_progression 
H-positive risk:  737 765 119 1093 349 108 1065 345 134 54 171 60 
H-negative risk:  765 737 1065 1093 345 349 108 119 171 134 60 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
87 
disease_progression 
H-positive risk:  743 770 115 1085 356 109 1051 349 137 52 173 60 
H-negative risk:  770 743 1051 1085 349 356 109 115 173 137 60 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
88 
disease_progression 
H-positive risk:  738 768 113 1093 358 109 1050 348 135 55 170 63 
H-negative risk:  768 738 1050 1093 348 358 109 113 170 135 63 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
89 
disease_progression 
H-positive risk:  741 767 112 1088 359 109 1056 350 136 52 169 61 
H-negative risk:  767 741 1056 1088 350 359 109 112 169 136 61 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
90 
disease_progression 
H-positive risk:  741 777 111 1089 359 109 1050 343 136 55 166 64 
H-negative risk:  777 741 1050 1089 343 359 109 111 166 136 64 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
91 
disease_progression 
H-positive risk:  743 774 114 1090 354 112 1057 342 137 53 166 58 
H-negative risk:  774 743 1057 1090 342 354 112 114 166 137 58 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
92 
disease_progression 
H-positive risk:  749 777 111 1089 349 111 1051 344 135 54 172 58 
H-negative risk:  777 749 1051 1089 344 349 111 111 172 135 58 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
93 
disease_progression 
H-positive risk:  754 779 110 1090 350 110 1060 336 131 51 173 56 
H-negative risk:  779 754 1060 1090 336 350 110 110 173 131 56 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
94 
disease_progression 
H-positive risk:  760 782 105 1084 354 107 1060 333 133 52 175 55 
H-negative risk:  782 760 1060 1084 333 354 107 105 175 133 55 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
95 
disease_progression 
H-positive risk:  762 785 104 1089 349 102 1050 339 138 53 172 57 
H-negative risk:  785 762 1050 1089 339 349 102 104 172 138 57 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
96 
disease_progression 
H-positive risk:  753 785 102 1092 347 102 1054 343 139 52 174 57 
H-negative risk:  785 753 1054 1092 343 347 102 102 174 139 57 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
97 
disease_progression 
H-positive risk:  699 740 93 1145 350 96 1101 343 142 51 182 58 
H-negative risk:  740 699 1101 1145 343 350 96 93 182 142 58 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
98 
disease_progression 
H-positive risk:  696 742 92 1135 362 98 1079 371 139 50 175 61 
H-negative risk:  742 696 1079 1135 371 362 98 92 175 139 61 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
99 
disease_progression 
H-positive risk:  696 747 93 1124 366 95 1079 373 144 48 173 62 
H-negative risk:  747 696 1079 1124 373 366 95 93 173 144 62 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
100 
disease_progression 
H-positive risk:  700 742 93 1129 357 100 1082 369 145 47 172 64 
H-negative risk:  742 700 1082 1129 369 357 100 93 172 145 64 47 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
101 
disease_progression 
H-positive risk:  705 732 93 1138 352 101 1084 366 145 46 172 66 
H-negative risk:  732 705 1084 1138 366 352 101 93 172 145 66 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
102 
disease_progression 
H-positive risk:  711 725 94 1142 356 103 1077 366 146 44 171 65 
H-negative risk:  725 711 1077 1142 366 356 103 94 171 146 65 44 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
103 
disease_progression 
H-positive risk:  709 721 94 1148 357 102 1073 362 151 46 173 64 
H-negative risk:  721 709 1073 1148 362 357 102 94 173 151 64 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
104 
disease_progression 
H-positive risk:  715 726 95 1147 360 101 1070 357 150 46 170 63 
H-negative risk:  726 715 1070 1147 357 360 101 95 170 150 63 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
105 
disease_progression 
H-positive risk:  717 723 95 1148 357 98 1074 358 151 47 169 63 
H-negative risk:  723 717 1074 1148 358 357 98 95 169 151 63 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
106 
disease_progression 
H-positive risk:  712 727 93 1147 354 100 1070 361 154 46 172 64 
H-negative risk:  727 712 1070 1147 361 354 100 93 172 154 64 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
107 
disease_progression 
H-positive risk:  712 727 94 1149 360 101 1063 359 154 48 169 64 
H-negative risk:  727 712 1063 1149 359 360 101 94 169 154 64 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
108 
disease_progression 
H-positive risk:  712 728 93 1147 361 100 1062 364 152 47 170 64 
H-negative risk:  728 712 1062 1147 364 361 100 93 170 152 64 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
109 
disease_progression 
H-positive risk:  666 688 89 1192 357 93 1102 361 162 49 178 63 
H-negative risk:  688 666 1102 1192 361 357 93 89 178 162 63 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
111 new agents 
110 
disease_progression 
H-positive risk:  676 692 90 1188 355 91 1088 366 161 52 176 65 
H-negative risk:  692 676 1088 1188 366 355 91 90 176 161 65 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
111 
disease_progression 
H-positive risk:  675 695 90 1184 356 92 1086 373 160 53 174 62 
H-negative risk:  695 675 1086 1184 373 356 92 90 174 160 62 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
112 
disease_progression 
H-positive risk:  673 693 88 1179 362 91 1081 381 158 56 174 64 
H-negative risk:  693 673 1081 1179 381 362 91 88 174 158 64 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
113 
disease_progression 
H-positive risk:  674 692 88 1178 362 90 1089 378 158 55 173 63 
H-negative risk:  692 674 1089 1178 378 362 90 88 173 158 63 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
114 
disease_progression 
H-positive risk:  671 689 89 1184 364 91 1082 377 163 55 171 64 
H-negative risk:  689 671 1082 1184 377 364 91 89 171 163 64 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
115 
disease_progression 
H-positive risk:  665 693 90 1193 361 89 1088 374 161 53 170 63 
H-negative risk:  693 665 1088 1193 374 361 89 90 170 161 63 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
116 
disease_progression 
H-positive risk:  670 695 91 1181 365 90 1087 380 160 54 165 62 
H-negative risk:  695 670 1087 1181 380 365 90 91 165 160 62 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
117 
disease_progression 
H-positive risk:  675 691 90 1184 357 91 1095 380 159 53 163 62 
H-negative risk:  691 675 1095 1184 380 357 91 90 163 159 62 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
118 
disease_progression 
H-positive risk:  679 681 90 1190 359 90 1093 376 160 55 165 62 
H-negative risk:  681 679 1093 1190 376 359 90 90 165 160 62 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
119 
disease_progression 
H-positive risk:  679 685 92 1181 359 89 1094 377 161 57 163 63 
H-negative risk:  685 679 1094 1181 377 359 89 92 163 161 63 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
120 
disease_progression 
H-positive risk:  687 687 91 1183 356 90 1097 374 157 58 158 62 
H-negative risk:  687 687 1097 1183 374 356 90 91 158 157 62 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
121 
disease_progression 
H-positive risk:  662 658 82 1214 355 87 1123 379 157 57 165 61 
H-negative risk:  658 662 1123 1214 379 355 87 82 165 157 61 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
122 
disease_progression 
H-positive risk:  660 655 80 1208 372 87 1119 381 154 58 164 62 
H-negative risk:  655 660 1119 1208 381 372 87 80 164 154 62 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
123 
disease_progression 
H-positive risk:  660 655 80 1203 371 84 1127 385 152 58 160 65 
H-negative risk:  655 660 1127 1203 385 371 84 80 160 152 65 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
124 
disease_progression 
H-positive risk:  670 658 81 1197 367 85 1127 381 153 56 160 65 
H-negative risk:  658 670 1127 1197 381 367 85 81 160 153 65 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
125 
disease_progression 
H-positive risk:  671 662 77 1205 360 83 1128 378 151 60 165 60 
H-negative risk:  662 671 1128 1205 378 360 83 77 165 151 60 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
126 
disease_progression 
H-positive risk:  673 659 75 1202 364 84 1123 381 149 60 169 61 
H-negative risk:  659 673 1123 1202 381 364 84 75 169 149 61 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
127 
disease_progression 
H-positive risk:  672 657 78 1209 363 83 1122 378 150 57 172 59 
H-negative risk:  657 672 1122 1209 378 363 83 78 172 150 59 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
128 
disease_progression 
H-positive risk:  677 652 76 1204 371 85 1129 373 148 56 172 57 
H-negative risk:  652 677 1129 1204 373 371 85 76 172 148 57 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
129 
disease_progression 
H-positive risk:  682 644 78 1204 374 86 1125 374 145 56 175 57 
H-negative risk:  644 682 1125 1204 374 374 86 78 175 145 57 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  684 644 78 1198 377 88 1124 379 144 56 174 54 
H-negative risk:  644 684 1124 1198 379 377 88 78 174 144 54 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
131 
disease_progression 
H-positive risk:  692 638 78 1198 377 92 1127 373 145 56 171 53 
H-negative risk:  638 692 1127 1198 373 377 92 78 171 145 53 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
132 
disease_progression 
H-positive risk:  692 641 79 1191 379 93 1124 375 145 53 174 54 
H-negative risk:  641 692 1124 1191 375 379 93 79 174 145 54 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
133 
disease_progression 
H-positive risk:  696 639 80 1200 376 94 1120 370 142 50 176 57 
H-negative risk:  639 696 1120 1200 370 376 94 80 176 142 57 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
134 
disease_progression 
H-positive risk:  689 629 81 1182 402 92 1123 376 139 50 179 58 
H-negative risk:  629 689 1123 1182 376 402 92 81 179 139 58 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
135 
disease_progression 
H-positive risk:  676 631 81 1185 401 91 1139 379 137 51 176 53 
H-negative risk:  631 676 1139 1185 379 401 91 81 176 137 53 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
136 
disease_progression 
H-positive risk:  675 646 81 1176 396 93 1142 371 138 52 177 53 
H-negative risk:  646 675 1142 1176 371 396 93 81 177 138 53 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
137 
disease_progression 
H-positive risk:  672 643 84 1174 393 93 1150 369 144 53 175 50 
H-negative risk:  643 672 1150 1174 369 393 93 84 175 144 50 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
138 
disease_progression 
H-positive risk:  670 645 83 1184 385 89 1155 366 143 54 175 51 
H-negative risk:  645 670 1155 1184 366 385 89 83 175 143 51 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
139 
disease_progression 
H-positive risk:  670 641 82 1192 387 90 1148 369 141 55 177 48 
H-negative risk:  641 670 1148 1192 369 387 90 82 177 141 48 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
140 
disease_progression 
H-positive risk:  660 641 82 1193 383 92 1157 368 142 56 177 49 
H-negative risk:  641 660 1157 1193 368 383 92 82 177 142 49 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
141 
disease_progression 
H-positive risk:  652 630 85 1199 382 91 1154 380 147 55 174 51 
H-negative risk:  630 652 1154 1199 380 382 91 85 174 147 51 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
142 
disease_progression 
H-positive risk:  643 635 89 1192 384 90 1159 383 145 56 175 49 
H-negative risk:  635 643 1159 1192 383 384 90 89 175 145 49 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
143 
disease_progression 
H-positive risk:  647 637 89 1188 385 89 1154 384 146 55 174 52 
H-negative risk:  637 647 1154 1188 384 385 89 89 174 146 52 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
144 
disease_progression 
H-positive risk:  646 637 88 1196 375 88 1159 380 150 52 177 52 
H-negative risk:  637 646 1159 1196 380 375 88 88 177 150 52 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
145 
disease_progression 
H-positive risk:  650 637 91 1195 366 84 1165 379 156 52 172 53 
H-negative risk:  637 650 1165 1195 379 366 84 91 172 156 53 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
146 
disease_progression 
H-positive risk:  644 634 89 1188 378 87 1162 385 156 51 170 56 
H-negative risk:  634 644 1162 1188 385 378 87 89 170 156 56 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
147 
disease_progression 
H-positive risk:  648 638 92 1180 382 86 1159 385 156 52 171 51 
H-negative risk:  638 648 1159 1180 385 382 86 92 171 156 51 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
148 
disease_progression 
H-positive risk:  654 636 91 1187 373 88 1155 386 159 50 170 51 
H-negative risk:  636 654 1155 1187 386 373 88 91 170 159 51 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
149 
disease_progression 
H-positive risk:  657 629 88 1201 375 89 1150 385 157 50 169 50 
H-negative risk:  629 657 1150 1201 385 375 89 88 169 157 50 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
150 
disease_progression 
H-positive risk:  656 627 87 1203 374 86 1153 388 157 53 167 49 
H-negative risk:  627 656 1153 1203 388 374 86 87 167 157 49 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 82 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
151 
disease_progression 
H-positive risk:  654 627 86 1201 374 85 1157 388 157 54 168 49 
H-negative risk:  627 654 1157 1201 388 374 85 86 168 157 49 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
152 
disease_progression 
H-positive risk:  653 635 89 1194 373 86 1161 382 155 55 168 49 
H-negative risk:  635 653 1161 1194 382 373 86 89 168 155 49 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
153 
disease_progression 
H-positive risk:  647 637 89 1191 377 84 1166 385 155 55 170 44 
H-negative risk:  637 647 1166 1191 385 377 84 89 170 155 44 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
154 
disease_progression 
H-positive risk:  646 636 89 1188 382 83 1168 388 155 54 168 43 
H-negative risk:  636 646 1168 1188 388 382 83 89 168 155 43 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
155 
disease_progression 
H-positive risk:  634 638 91 1196 381 84 1172 388 154 52 169 41 
H-negative risk:  638 634 1172 1196 388 381 84 91 169 154 41 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
156 
disease_progression 
H-positive risk:  627 644 91 1203 370 86 1170 385 155 54 171 44 
H-negative risk:  644 627 1170 1203 385 370 86 91 171 155 44 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
157 
disease_progression 
H-positive risk:  627 648 94 1197 372 84 1172 383 156 54 172 41 
H-negative risk:  648 627 1172 1197 383 372 84 94 172 156 41 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
99 new agents 
158 
disease_progression 
H-positive risk:  633 646 98 1193 386 82 1153 381 158 54 173 43 
H-negative risk:  646 633 1153 1193 381 386 82 98 173 158 43 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
159 
disease_progression 
H-positive risk:  634 652 95 1188 384 79 1142 392 160 54 176 44 
H-negative risk:  652 634 1142 1188 392 384 79 95 176 160 44 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
160 
disease_progression 
H-positive risk:  643 650 96 1185 390 77 1142 393 157 52 171 44 
H-negative risk:  650 643 1142 1185 393 390 77 96 171 157 44 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
161 
disease_progression 
H-positive risk:  647 659 96 1176 387 76 1139 399 155 50 171 45 
H-negative risk:  659 647 1139 1176 399 387 76 96 171 155 45 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
162 
disease_progression 
H-positive risk:  644 645 97 1176 396 75 1143 397 156 51 173 47 
H-negative risk:  645 644 1143 1176 397 396 75 97 173 156 47 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
163 
disease_progression 
H-positive risk:  638 645 96 1177 400 76 1142 395 157 54 171 49 
H-negative risk:  645 638 1142 1177 395 400 76 96 171 157 49 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
164 
disease_progression 
H-positive risk:  641 647 96 1171 397 81 1147 387 158 55 170 50 
H-negative risk:  647 641 1147 1171 387 397 81 96 170 158 50 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
165 
disease_progression 
H-positive risk:  637 655 97 1167 396 81 1143 393 156 56 167 52 
H-negative risk:  655 637 1143 1167 393 396 81 97 167 156 52 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
166 
disease_progression 
H-positive risk:  641 655 97 1166 392 82 1139 395 156 55 170 52 
H-negative risk:  655 641 1139 1166 395 392 82 97 170 156 52 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
167 
disease_progression 
H-positive risk:  643 657 97 1159 393 81 1137 397 154 54 175 53 
H-negative risk:  657 643 1137 1159 397 393 81 97 175 154 53 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
168 
disease_progression 
H-positive risk:  650 657 98 1165 388 81 1133 393 152 55 177 51 
H-negative risk:  657 650 1133 1165 393 388 81 98 177 152 51 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
169 
disease_progression 
H-positive risk:  653 653 97 1168 389 82 1123 396 155 57 176 51 
H-negative risk:  653 653 1123 1168 396 389 82 97 176 155 51 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
170 
disease_progression 
H-positive risk:  652 662 96 1156 403 81 1115 404 150 59 173 49 
H-negative risk:  662 652 1115 1156 404 403 81 96 173 150 49 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
171 
disease_progression 
H-positive risk:  650 656 100 1169 394 80 1113 404 150 59 173 52 
H-negative risk:  656 650 1113 1169 404 394 80 100 173 150 52 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
172 
disease_progression 
H-positive risk:  651 664 99 1154 401 79 1110 402 156 57 174 53 
H-negative risk:  664 651 1110 1154 402 401 79 99 174 156 53 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
173 
disease_progression 
H-positive risk:  649 670 96 1154 392 79 1121 399 151 59 175 55 
H-negative risk:  670 649 1121 1154 399 392 79 96 175 151 55 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
174 
disease_progression 
H-positive risk:  648 670 93 1158 391 80 1126 393 151 58 176 56 
H-negative risk:  670 648 1126 1158 393 391 80 93 176 151 56 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
175 
disease_progression 
H-positive risk:  653 676 90 1152 394 82 1117 393 152 57 176 58 
H-negative risk:  676 653 1117 1152 393 394 82 90 176 152 58 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
176 
disease_progression 
H-positive risk:  649 679 92 1161 385 81 1115 395 154 58 176 55 
H-negative risk:  679 649 1115 1161 395 385 81 92 176 154 55 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
177 
disease_progression 
H-positive risk:  648 679 89 1163 388 83 1109 394 154 58 179 56 
H-negative risk:  679 648 1109 1163 394 388 83 89 179 154 56 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
178 
disease_progression 
H-positive risk:  651 685 89 1149 393 85 1106 400 154 54 177 57 
H-negative risk:  685 651 1106 1149 400 393 85 89 177 154 57 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
179 
disease_progression 
H-positive risk:  643 686 89 1153 393 81 1108 403 155 54 179 56 
H-negative risk:  686 643 1108 1153 403 393 81 89 179 155 56 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
180 
disease_progression 
H-positive risk:  637 684 86 1159 395 81 1112 400 155 52 183 56 
H-negative risk:  684 637 1112 1159 400 395 81 86 183 155 56 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
181 
disease_progression 
H-positive risk:  645 681 84 1150 401 83 1118 391 150 55 186 56 
H-negative risk:  681 645 1118 1150 391 401 83 84 186 150 56 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
182 
disease_progression 
H-positive risk:  647 674 85 1135 417 81 1112 408 149 55 177 60 
H-negative risk:  674 647 1112 1135 408 417 81 85 177 149 60 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  651 664 85 1138 412 80 1122 404 151 55 177 61 
H-negative risk:  664 651 1122 1138 404 412 80 85 177 151 61 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
184 
disease_progression 
H-positive risk:  649 658 85 1139 410 81 1128 407 151 55 177 60 
H-negative risk:  658 649 1128 1139 407 410 81 85 177 151 60 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
185 
disease_progression 
H-positive risk:  650 658 88 1140 414 82 1117 405 151 55 177 63 
H-negative risk:  658 650 1117 1140 405 414 82 88 177 151 63 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
186 
disease_progression 
H-positive risk:  658 654 88 1143 417 82 1112 402 155 53 176 60 
H-negative risk:  654 658 1112 1143 402 417 82 88 176 155 60 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
187 
disease_progression 
H-positive risk:  652 662 88 1147 413 82 1112 399 157 52 179 57 
H-negative risk:  662 652 1112 1147 399 413 82 88 179 157 57 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
188 
disease_progression 
H-positive risk:  644 667 89 1143 415 80 1114 395 162 53 182 56 
H-negative risk:  667 644 1114 1143 395 415 80 89 182 162 56 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  650 661 88 1145 410 81 1118 398 162 50 184 53 
H-negative risk:  661 650 1118 1145 398 410 81 88 184 162 53 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
190 
disease_progression 
H-positive risk:  649 656 88 1150 406 83 1127 392 162 52 183 52 
H-negative risk:  656 649 1127 1150 392 406 83 88 183 162 52 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
191 
disease_progression 
H-positive risk:  652 655 87 1156 403 82 1120 394 164 53 183 51 
H-negative risk:  655 652 1120 1156 394 403 82 87 183 164 51 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
192 
disease_progression 
H-positive risk:  649 659 89 1153 407 82 1116 393 164 53 179 56 
H-negative risk:  659 649 1116 1153 393 407 82 89 179 164 56 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
193 
disease_progression 
H-positive risk:  650 653 90 1158 403 83 1114 397 164 52 179 57 
H-negative risk:  653 650 1114 1158 397 403 83 90 179 164 57 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
96 new agents 
194 
disease_progression 
H-positive risk:  647 661 92 1151 404 83 1107 401 168 49 180 57 
H-negative risk:  661 647 1107 1151 401 404 83 92 180 168 57 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
195 
disease_progression 
H-positive risk:  649 667 90 1137 415 83 1114 390 169 47 181 58 
H-negative risk:  667 649 1114 1137 390 415 83 90 181 169 58 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
196 
disease_progression 
H-positive risk:  656 658 91 1138 413 86 1117 388 169 47 183 54 
H-negative risk:  658 656 1117 1138 388 413 86 91 183 169 54 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
197 
disease_progression 
H-positive risk:  661 659 92 1135 411 84 1117 384 169 49 185 54 
H-negative risk:  659 661 1117 1135 384 411 84 92 185 169 54 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
198 
disease_progression 
H-positive risk:  660 661 93 1135 419 87 1104 383 167 51 186 54 
H-negative risk:  661 660 1104 1135 383 419 87 93 186 167 54 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
199 
disease_progression 
H-positive risk:  668 661 91 1139 420 89 1082 391 168 52 186 53 
H-negative risk:  661 668 1082 1139 391 420 89 91 186 168 53 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
200 
disease_progression 
H-positive risk:  671 658 95 1138 426 87 1081 389 165 53 184 53 
H-negative risk:  658 671 1081 1138 389 426 87 95 184 165 53 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
201 
disease_progression 
H-positive risk:  673 654 92 1140 429 86 1089 386 163 54 181 53 
H-negative risk:  654 673 1089 1140 386 429 86 92 181 163 53 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
202 
disease_progression 
H-positive risk:  670 659 91 1136 433 88 1074 399 162 57 177 54 
H-negative risk:  659 670 1074 1136 399 433 88 91 177 162 54 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
203 
disease_progression 
H-positive risk:  665 660 91 1137 432 88 1069 408 161 58 176 55 
H-negative risk:  660 665 1069 1137 408 432 88 91 176 161 55 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
204 
disease_progression 
H-positive risk:  676 654 90 1129 436 90 1072 404 160 60 176 53 
H-negative risk:  654 676 1072 1129 404 436 90 90 176 160 53 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
205 
disease_progression 
H-positive risk:  682 656 88 1127 433 88 1079 400 159 62 173 53 
H-negative risk:  656 682 1079 1127 400 433 88 88 173 159 53 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
57 new agents 
206 
disease_progression 
H-positive risk:  678 659 87 1119 445 85 1075 404 156 64 173 55 
H-negative risk:  659 678 1075 1119 404 445 85 87 173 156 55 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
102 new agents 
207 
disease_progression 
H-positive risk:  679 668 85 1114 438 87 1070 404 154 69 174 58 
H-negative risk:  668 679 1070 1114 404 438 87 85 174 154 58 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
208 
disease_progression 
H-positive risk:  669 674 84 1114 432 85 1081 406 151 71 175 58 
H-negative risk:  674 669 1081 1114 406 432 85 84 175 151 58 71 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
209 
disease_progression 
H-positive risk:  669 672 87 1122 432 87 1078 402 150 71 172 58 
H-negative risk:  672 669 1078 1122 402 432 87 87 172 150 58 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
210 
disease_progression 
H-positive risk:  668 673 88 1117 434 88 1078 405 150 70 173 56 
H-negative risk:  673 668 1078 1117 405 434 88 88 173 150 56 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
211 
disease_progression 
H-positive risk:  679 680 89 1115 429 90 1072 399 147 71 172 57 
H-negative risk:  680 679 1072 1115 399 429 90 89 172 147 57 71 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
212 
disease_progression 
H-positive risk:  683 692 88 1115 430 87 1061 399 151 70 171 53 
H-negative risk:  692 683 1061 1115 399 430 87 88 171 151 53 70 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
213 
disease_progression 
H-positive risk:  687 685 87 1122 427 86 1063 399 148 70 171 55 
H-negative risk:  685 687 1063 1122 399 427 86 87 171 148 55 70 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
214 
disease_progression 
H-positive risk:  689 676 87 1130 426 87 1059 400 150 72 171 53 
H-negative risk:  676 689 1059 1130 400 426 87 87 171 150 53 72 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
215 
disease_progression 
H-positive risk:  695 672 87 1124 429 86 1070 399 143 70 172 53 
H-negative risk:  672 695 1070 1124 399 429 86 87 172 143 53 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
216 
disease_progression 
H-positive risk:  681 676 86 1115 435 87 1079 405 140 68 172 56 
H-negative risk:  676 681 1079 1115 405 435 87 86 172 140 56 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
217 
disease_progression 
H-positive risk:  684 675 84 1096 449 87 1071 418 140 67 170 59 
H-negative risk:  675 684 1071 1096 418 449 87 84 170 140 59 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
218 
disease_progression 
H-positive risk:  682 673 86 1095 454 86 1072 413 139 68 173 59 
H-negative risk:  673 682 1072 1095 413 454 86 86 173 139 59 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
219 
disease_progression 
H-positive risk:  682 672 84 1106 452 85 1066 419 137 68 173 56 
H-negative risk:  672 682 1066 1106 419 452 85 84 173 137 56 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
220 
disease_progression 
H-positive risk:  681 666 84 1099 462 86 1060 423 140 67 171 61 
H-negative risk:  666 681 1060 1099 423 462 86 84 171 140 61 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
221 
disease_progression 
H-positive risk:  684 673 82 1084 464 84 1062 424 141 65 175 62 
H-negative risk:  673 684 1062 1084 424 464 84 82 175 141 62 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
222 
disease_progression 
H-positive risk:  682 675 82 1093 460 85 1060 424 142 63 170 64 
H-negative risk:  675 682 1060 1093 424 460 85 82 170 142 64 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
223 
disease_progression 
H-positive risk:  683 682 80 1083 459 85 1067 423 140 63 173 62 
H-negative risk:  682 683 1067 1083 423 459 85 80 173 140 62 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
224 
disease_progression 
H-positive risk:  682 680 81 1073 455 85 1081 423 141 62 174 63 
H-negative risk:  680 682 1081 1073 423 455 85 81 174 141 63 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
225 
disease_progression 
H-positive risk:  686 680 81 1076 459 89 1076 417 138 61 176 61 
H-negative risk:  680 686 1076 1076 417 459 89 81 176 138 61 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
226 
disease_progression 
H-positive risk:  687 688 80 1084 459 91 1075 408 134 59 174 61 
H-negative risk:  688 687 1075 1084 408 459 91 80 174 134 61 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
96 new agents 
227 
disease_progression 
H-positive risk:  698 689 82 1082 459 92 1072 402 131 62 172 59 
H-negative risk:  689 698 1072 1082 402 459 92 82 172 131 59 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
228 
disease_progression 
H-positive risk:  697 676 83 1084 461 90 1077 402 135 63 174 58 
H-negative risk:  676 697 1077 1084 402 461 90 83 174 135 58 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
229 
disease_progression 
H-positive risk:  691 679 87 1074 465 90 1064 419 137 63 175 56 
H-negative risk:  679 691 1064 1074 419 465 90 87 175 137 56 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
101 new agents 
230 
disease_progression 
H-positive risk:  686 686 88 1077 451 88 1077 425 136 59 170 57 
H-negative risk:  686 686 1077 1077 425 451 88 88 170 136 57 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
231 
disease_progression 
H-positive risk:  680 677 88 1076 457 89 1081 424 138 56 174 60 
H-negative risk:  677 680 1081 1076 424 457 89 88 174 138 60 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
232 
disease_progression 
H-positive risk:  678 675 85 1083 453 89 1085 423 140 52 177 60 
H-negative risk:  675 678 1085 1083 423 453 89 85 177 140 60 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
233 
disease_progression 
H-positive risk:  682 681 84 1093 449 88 1080 414 140 52 177 60 
H-negative risk:  681 682 1080 1093 414 449 88 84 177 140 60 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
234 
disease_progression 
H-positive risk:  681 685 85 1088 448 87 1078 416 142 52 178 60 
H-negative risk:  685 681 1078 1088 416 448 87 85 178 142 60 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
235 
disease_progression 
H-positive risk:  687 690 84 1088 444 81 1077 412 144 54 181 58 
H-negative risk:  690 687 1077 1088 412 444 81 84 181 144 58 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
236 
disease_progression 
H-positive risk:  681 684 85 1085 439 83 1087 417 143 55 183 58 
H-negative risk:  684 681 1087 1085 417 439 83 85 183 143 58 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
237 
disease_progression 
H-positive risk:  685 685 85 1084 432 82 1089 422 145 53 178 60 
H-negative risk:  685 685 1089 1084 422 432 82 85 178 145 60 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
238 
disease_progression 
H-positive risk:  685 693 86 1075 435 82 1087 424 145 53 179 56 
H-negative risk:  693 685 1087 1075 424 435 82 86 179 145 56 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
239 
disease_progression 
H-positive risk:  687 693 84 1081 437 83 1081 424 141 56 179 54 
H-negative risk:  693 687 1081 1081 424 437 83 84 179 141 54 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
240 
disease_progression 
H-positive risk:  692 694 83 1079 432 83 1080 425 138 60 179 55 
H-negative risk:  694 692 1080 1079 425 432 83 83 179 138 55 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
241 
disease_progression 
H-positive risk:  691 694 82 1069 435 85 1083 427 138 60 177 59 
H-negative risk:  694 691 1083 1069 427 435 85 82 177 138 59 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
242 
disease_progression 
H-positive risk:  691 687 77 1081 433 83 1083 426 143 60 178 58 
H-negative risk:  687 691 1083 1081 426 433 83 77 178 143 58 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
243 
disease_progression 
H-positive risk:  693 686 74 1075 439 85 1089 422 141 59 179 58 
H-negative risk:  686 693 1089 1075 422 439 85 74 179 141 58 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
244 
disease_progression 
H-positive risk:  678 687 72 1075 444 84 1086 429 142 59 185 59 
H-negative risk:  687 678 1086 1075 429 444 84 72 185 142 59 59 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
245 
disease_progression 
H-positive risk:  677 685 77 1077 437 84 1084 434 144 61 182 58 
H-negative risk:  685 677 1084 1077 434 437 84 77 182 144 58 61 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 98 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
246 
disease_progression 
H-positive risk:  689 688 75 1078 432 85 1081 430 138 63 180 61 
H-negative risk:  688 689 1081 1078 430 432 85 75 180 138 61 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
247 
disease_progression 
H-positive risk:  691 685 73 1075 442 88 1078 420 138 66 183 61 
H-negative risk:  685 691 1078 1075 420 442 88 73 183 138 61 66 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
248 
disease_progression 
H-positive risk:  687 681 74 1077 444 88 1077 420 139 67 184 62 
H-negative risk:  681 687 1077 1077 420 444 88 74 184 139 62 67 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
249 
disease_progression 
H-positive risk:  691 677 72 1076 442 88 1080 424 139 66 182 63 
H-negative risk:  677 691 1080 1076 424 442 88 72 182 139 63 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
250 
disease_progression 
H-positive risk:  691 679 73 1072 443 87 1081 421 142 66 180 65 
H-negative risk:  679 691 1081 1072 421 443 87 73 180 142 65 66 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
251 
disease_progression 
H-positive risk:  689 674 74 1085 443 86 1083 415 141 65 178 67 
H-negative risk:  674 689 1083 1085 415 443 86 74 178 141 67 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
252 
disease_progression 
H-positive risk:  687 673 74 1090 451 90 1077 414 138 65 177 64 
H-negative risk:  673 687 1077 1090 414 451 90 74 177 138 64 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
253 
disease_progression 
H-positive risk:  686 671 79 1091 447 92 1087 407 135 67 173 65 
H-negative risk:  671 686 1087 1091 407 447 92 79 173 135 65 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
254 
disease_progression 
H-positive risk:  693 683 81 1079 443 92 1086 409 134 65 170 65 
H-negative risk:  683 693 1086 1079 409 443 92 81 170 134 65 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
255 
disease_progression 
H-positive risk:  696 682 82 1069 440 94 1085 417 133 68 166 68 
H-negative risk:  682 696 1085 1069 417 440 94 82 166 133 68 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
256 
disease_progression 
H-positive risk:  700 679 83 1074 439 93 1072 420 138 69 166 67 
H-negative risk:  679 700 1072 1074 420 439 93 83 166 138 67 69 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
257 
disease_progression 
H-positive risk:  693 674 83 1080 437 93 1076 423 137 71 161 72 
H-negative risk:  674 693 1076 1080 423 437 93 83 161 137 72 71 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
258 
disease_progression 
H-positive risk:  696 667 85 1085 436 94 1075 422 138 70 159 73 
H-negative risk:  667 696 1075 1085 422 436 94 85 159 138 73 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
259 
disease_progression 
H-positive risk:  697 669 83 1074 436 94 1087 426 135 66 158 75 
H-negative risk:  669 697 1087 1074 426 436 94 83 158 135 75 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
260 
disease_progression 
H-positive risk:  696 672 84 1072 437 95 1084 429 133 66 157 75 
H-negative risk:  672 696 1084 1072 429 437 95 84 157 133 75 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
261 
disease_progression 
H-positive risk:  679 673 89 1077 433 96 1100 428 134 64 151 76 
H-negative risk:  673 679 1100 1077 428 433 96 89 151 134 76 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
262 
disease_progression 
H-positive risk:  672 669 89 1084 436 91 1106 425 137 65 153 73 
H-negative risk:  669 672 1106 1084 425 436 91 89 153 137 73 65 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
263 
disease_progression 
H-positive risk:  671 666 90 1083 434 92 1106 423 138 68 152 77 
H-negative risk:  666 671 1106 1083 423 434 92 90 152 138 77 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
264 
disease_progression 
H-positive risk:  670 672 87 1084 435 88 1100 430 140 69 151 74 
H-negative risk:  672 670 1100 1084 430 435 88 87 151 140 74 69 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
265 
disease_progression 
H-positive risk:  663 666 88 1089 435 90 1102 429 141 69 154 74 
H-negative risk:  666 663 1102 1089 429 435 90 88 154 141 74 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
266 
disease_progression 
H-positive risk:  662 656 85 1091 434 93 1103 433 138 67 161 77 
H-negative risk:  656 662 1103 1091 433 434 93 85 161 138 77 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
267 
disease_progression 
H-positive risk:  668 648 83 1083 436 96 1099 444 138 64 163 78 
H-negative risk:  648 668 1099 1083 444 436 96 83 163 138 78 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
268 
disease_progression 
H-positive risk:  672 649 82 1084 425 97 1112 441 138 60 164 76 
H-negative risk:  649 672 1112 1084 441 425 97 82 164 138 76 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
269 
disease_progression 
H-positive risk:  663 659 82 1078 426 96 1123 436 137 62 161 77 
H-negative risk:  659 663 1123 1078 436 426 96 82 161 137 77 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
270 
disease_progression 
H-positive risk:  660 655 88 1072 429 96 1127 439 137 59 158 80 
H-negative risk:  655 660 1127 1072 439 429 96 88 158 137 80 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
271 
disease_progression 
H-positive risk:  654 651 90 1073 427 96 1135 438 136 60 155 85 
H-negative risk:  651 654 1135 1073 438 427 96 90 155 136 85 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
272 
disease_progression 
H-positive risk:  652 663 86 1069 423 100 1135 433 140 57 160 82 
H-negative risk:  663 652 1135 1069 433 423 100 86 160 140 82 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
273 
disease_progression 
H-positive risk:  649 657 85 1076 425 98 1142 426 144 59 158 81 
H-negative risk:  657 649 1142 1076 426 425 98 85 158 144 81 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
274 
disease_progression 
H-positive risk:  648 657 83 1079 427 98 1141 426 144 60 160 77 
H-negative risk:  657 648 1141 1079 426 427 98 83 160 144 77 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
275 
disease_progression 
H-positive risk:  649 654 84 1071 434 98 1140 429 145 57 161 78 
H-negative risk:  654 649 1140 1071 429 434 98 84 161 145 78 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
276 
disease_progression 
H-positive risk:  645 650 84 1078 432 100 1145 424 148 54 161 79 
H-negative risk:  650 645 1145 1078 424 432 100 84 161 148 79 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
277 
disease_progression 
H-positive risk:  643 657 83 1076 436 100 1143 425 150 56 156 75 
H-negative risk:  657 643 1143 1076 425 436 100 83 156 150 75 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
101 new agents 
278 
disease_progression 
H-positive risk:  654 663 86 1081 421 99 1140 420 153 54 156 73 
H-negative risk:  663 654 1140 1081 420 421 99 86 156 153 73 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
279 
disease_progression 
H-positive risk:  654 663 87 1075 424 96 1130 423 158 56 158 76 
H-negative risk:  663 654 1130 1075 423 424 96 87 158 158 76 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
280 
disease_progression 
H-positive risk:  658 657 86 1075 417 97 1138 421 156 61 154 80 
H-negative risk:  657 658 1138 1075 421 417 97 86 154 156 80 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
281 
disease_progression 
H-positive risk:  662 647 85 1079 415 99 1142 421 154 60 156 80 
H-negative risk:  647 662 1142 1079 421 415 99 85 156 154 80 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  666 651 82 1080 411 99 1146 414 154 61 154 82 
H-negative risk:  651 666 1146 1080 414 411 99 82 154 154 82 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
283 
disease_progression 
H-positive risk:  668 650 85 1078 414 97 1146 418 153 56 155 80 
H-negative risk:  650 668 1146 1078 418 414 97 85 155 153 80 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
284 
disease_progression 
H-positive risk:  667 652 84 1077 415 94 1147 423 157 53 153 78 
H-negative risk:  652 667 1147 1077 423 415 94 84 153 157 78 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
285 
disease_progression 
H-positive risk:  671 654 86 1078 408 96 1142 426 151 57 154 77 
H-negative risk:  654 671 1142 1078 426 408 96 86 154 151 77 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
286 
disease_progression 
H-positive risk:  667 656 89 1074 413 98 1141 424 150 56 154 78 
H-negative risk:  656 667 1141 1074 424 413 98 89 154 150 78 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
287 
disease_progression 
H-positive risk:  659 659 85 1082 410 100 1145 418 153 53 160 76 
H-negative risk:  659 659 1145 1082 418 410 100 85 160 153 76 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
288 
disease_progression 
H-positive risk:  650 662 86 1077 410 98 1145 427 156 52 157 80 
H-negative risk:  662 650 1145 1077 427 410 98 86 157 156 80 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
289 
disease_progression 
H-positive risk:  651 664 88 1088 410 96 1130 428 157 51 157 80 
H-negative risk:  664 651 1130 1088 428 410 96 88 157 157 80 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
290 
disease_progression 
H-positive risk:  651 665 91 1099 410 93 1132 415 158 53 158 75 
H-negative risk:  665 651 1132 1099 415 410 93 91 158 158 75 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
291 
disease_progression 
H-positive risk:  652 671 92 1096 410 94 1121 421 157 53 159 74 
H-negative risk:  671 652 1121 1096 421 410 94 92 159 157 74 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
292 
disease_progression 
H-positive risk:  649 680 93 1093 418 91 1119 420 152 53 162 70 
H-negative risk:  680 649 1119 1093 420 418 91 93 162 152 70 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
293 
disease_progression 
H-positive risk:  656 676 93 1095 417 94 1114 416 152 52 161 74 
H-negative risk:  676 656 1114 1095 416 417 94 93 161 152 74 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
294 
disease_progression 
H-positive risk:  662 677 92 1097 416 94 1114 413 150 52 160 73 
H-negative risk:  677 662 1114 1097 413 416 94 92 160 150 73 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
95 new agents 
295 
disease_progression 
H-positive risk:  669 681 94 1091 406 95 1111 417 148 56 160 72 
H-negative risk:  681 669 1111 1091 417 406 95 94 160 148 72 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
296 
disease_progression 
H-positive risk:  666 681 96 1092 408 91 1115 415 152 57 159 68 
H-negative risk:  681 666 1115 1092 415 408 91 96 159 152 68 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
297 
disease_progression 
H-positive risk:  671 683 97 1083 408 89 1110 420 153 58 159 69 
H-negative risk:  683 671 1110 1083 420 408 89 97 159 153 69 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
298 
disease_progression 
H-positive risk:  677 686 98 1073 398 92 1115 419 153 59 159 71 
H-negative risk:  686 677 1115 1073 419 398 92 98 159 153 71 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
299 
disease_progression 
H-positive risk:  678 694 99 1070 401 90 1100 430 154 59 157 68 
H-negative risk:  694 678 1100 1070 430 401 90 99 157 154 68 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
300 
disease_progression 
H-positive risk:  680 692 97 1070 400 91 1106 427 155 56 159 67 
H-negative risk:  692 680 1106 1070 427 400 91 97 159 155 67 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
301 
disease_progression 
H-positive risk:  680 692 96 1066 404 94 1104 428 151 59 159 67 
H-negative risk:  692 680 1104 1066 428 404 94 96 159 151 67 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
302 
disease_progression 
H-positive risk:  673 691 97 1063 406 95 1115 427 152 56 160 65 
H-negative risk:  691 673 1115 1063 427 406 95 97 160 152 65 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
303 
disease_progression 
H-positive risk:  670 691 96 1059 405 95 1112 435 154 56 163 64 
H-negative risk:  691 670 1112 1059 435 405 95 96 163 154 64 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
304 
disease_progression 
H-positive risk:  679 691 95 1067 399 94 1108 431 151 61 162 62 
H-negative risk:  691 679 1108 1067 431 399 94 95 162 151 62 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
305 
disease_progression 
H-positive risk:  681 689 94 1066 397 94 1110 431 153 57 164 64 
H-negative risk:  689 681 1110 1066 431 397 94 94 164 153 64 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
92 new agents 
306 
disease_progression 
H-positive risk:  679 694 95 1067 387 97 1114 432 153 55 163 64 
H-negative risk:  694 679 1114 1067 432 387 97 95 163 153 64 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
307 
disease_progression 
H-positive risk:  676 689 101 1071 383 101 1119 428 151 54 166 61 
H-negative risk:  689 676 1119 1071 428 383 101 101 166 151 61 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
308 
disease_progression 
H-positive risk:  677 688 98 1071 384 103 1116 428 150 55 167 63 
H-negative risk:  688 677 1116 1071 428 384 103 98 167 150 63 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
309 
disease_progression 
H-positive risk:  674 702 99 1065 383 104 1111 428 148 57 164 65 
H-negative risk:  702 674 1111 1065 428 383 104 99 164 148 65 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
310 
disease_progression 
H-positive risk:  674 696 101 1071 389 106 1100 431 146 59 160 67 
H-negative risk:  696 674 1100 1071 431 389 106 101 160 146 67 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
311 
disease_progression 
H-positive risk:  673 681 102 1080 397 107 1097 432 144 58 162 67 
H-negative risk:  681 673 1097 1080 432 397 107 102 162 144 67 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
312 
disease_progression 
H-positive risk:  673 684 105 1077 401 105 1097 431 144 57 157 69 
H-negative risk:  684 673 1097 1077 431 401 105 105 157 144 69 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
313 
disease_progression 
H-positive risk:  681 683 103 1077 397 102 1091 436 145 57 158 70 
H-negative risk:  683 681 1091 1077 436 397 102 103 158 145 70 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
314 
disease_progression 
H-positive risk:  679 684 100 1082 403 105 1092 428 143 57 159 68 
H-negative risk:  684 679 1092 1082 428 403 105 100 159 143 68 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
98 new agents 
315 
disease_progression 
H-positive risk:  667 690 103 1081 404 106 1091 433 142 57 159 67 
H-negative risk:  690 667 1091 1081 433 404 106 103 159 142 67 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
316 
disease_progression 
H-positive risk:  668 698 100 1075 409 106 1087 427 146 59 156 69 
H-negative risk:  698 668 1087 1075 427 409 106 100 156 146 69 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
317 
disease_progression 
H-positive risk:  666 696 100 1072 411 107 1087 433 148 57 157 66 
H-negative risk:  696 666 1087 1072 433 411 107 100 157 148 66 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
318 
disease_progression 
H-positive risk:  665 704 100 1074 416 104 1081 433 152 56 154 61 
H-negative risk:  704 665 1081 1074 433 416 104 100 154 152 61 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
319 
disease_progression 
H-positive risk:  663 702 103 1070 417 101 1090 428 157 57 150 62 
H-negative risk:  702 663 1090 1070 428 417 101 103 150 157 62 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
320 
disease_progression 
H-positive risk:  655 695 104 1077 422 101 1090 431 156 59 148 62 
H-negative risk:  695 655 1090 1077 431 422 101 104 148 156 62 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
321 
disease_progression 
H-positive risk:  655 695 104 1085 425 101 1083 428 153 60 149 62 
H-negative risk:  695 655 1083 1085 428 425 101 104 149 153 62 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
322 
disease_progression 
H-positive risk:  653 696 103 1085 421 102 1090 421 156 61 151 61 
H-negative risk:  696 653 1090 1085 421 421 102 103 151 156 61 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
323 
disease_progression 
H-positive risk:  655 704 104 1077 425 102 1093 412 155 59 149 65 
H-negative risk:  704 655 1093 1077 412 425 102 104 149 155 65 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
324 
disease_progression 
H-positive risk:  664 708 106 1079 423 102 1088 405 155 55 151 64 
H-negative risk:  708 664 1088 1079 405 423 102 106 151 155 64 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
325 
disease_progression 
H-positive risk:  667 707 106 1077 417 102 1082 413 155 59 151 64 
H-negative risk:  707 667 1082 1077 413 417 102 106 151 155 64 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
326 
disease_progression 
H-positive risk:  672 707 105 1083 411 101 1085 404 159 60 152 61 
H-negative risk:  707 672 1085 1083 404 411 101 105 152 159 61 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
327 
disease_progression 
H-positive risk:  677 708 104 1084 405 101 1086 401 161 62 151 60 
H-negative risk:  708 677 1086 1084 401 405 101 104 151 161 60 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
328 
disease_progression 
H-positive risk:  676 703 109 1096 404 97 1088 395 161 62 148 61 
H-negative risk:  703 676 1088 1096 395 404 97 109 148 161 61 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
329 
disease_progression 
H-positive risk:  676 697 109 1102 406 97 1083 397 159 61 150 63 
H-negative risk:  697 676 1083 1102 397 406 97 109 150 159 63 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
330 
disease_progression 
H-positive risk:  671 691 110 1099 415 102 1078 404 159 61 151 59 
H-negative risk:  691 671 1078 1099 404 415 102 110 151 159 59 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
331 
disease_progression 
H-positive risk:  679 686 108 1104 410 104 1078 403 158 63 148 59 
H-negative risk:  686 679 1078 1104 403 410 104 108 148 158 59 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
332 
disease_progression 
H-positive risk:  684 686 104 1111 405 103 1079 397 156 63 150 62 
H-negative risk:  686 684 1079 1111 397 405 103 104 150 156 62 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
333 
disease_progression 
H-positive risk:  687 686 103 1100 408 104 1078 399 158 60 153 64 
H-negative risk:  686 687 1078 1100 399 408 104 103 153 158 64 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
334 
disease_progression 
H-positive risk:  692 681 103 1105 409 105 1073 400 158 60 152 62 
H-negative risk:  681 692 1073 1105 400 409 105 103 152 158 62 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
335 
disease_progression 
H-positive risk:  695 682 103 1105 410 106 1070 401 156 61 150 61 
H-negative risk:  682 695 1070 1105 401 410 106 103 150 156 61 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
336 
disease_progression 
H-positive risk:  698 683 102 1107 408 104 1062 404 160 59 154 59 
H-negative risk:  683 698 1062 1107 404 408 104 102 154 160 59 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
337 
disease_progression 
H-positive risk:  706 683 105 1102 406 104 1060 401 165 59 154 55 
H-negative risk:  683 706 1060 1102 401 406 104 105 154 165 55 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
338 
disease_progression 
H-positive risk:  702 681 107 1089 405 106 1069 408 164 59 153 57 
H-negative risk:  681 702 1069 1089 408 405 106 107 153 164 57 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  699 680 106 1090 402 107 1073 410 164 58 155 56 
H-negative risk:  680 699 1073 1090 410 402 107 106 155 164 56 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
340 
disease_progression 
H-positive risk:  699 679 107 1087 404 107 1080 410 160 58 153 56 
H-negative risk:  679 699 1080 1087 410 404 107 107 153 160 56 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  706 684 107 1087 399 106 1067 417 156 59 155 57 
H-negative risk:  684 706 1067 1087 417 399 106 107 155 156 57 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
342 
disease_progression 
H-positive risk:  706 682 105 1087 405 103 1060 426 158 58 155 55 
H-negative risk:  682 706 1060 1087 426 405 103 105 155 158 55 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
343 
disease_progression 
H-positive risk:  707 685 109 1083 406 104 1059 420 155 59 155 58 
H-negative risk:  685 707 1059 1083 420 406 104 109 155 155 58 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
344 
disease_progression 
H-positive risk:  701 683 108 1085 413 108 1064 420 152 57 153 56 
H-negative risk:  683 701 1064 1085 420 413 108 108 153 152 56 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
345 
disease_progression 
H-positive risk:  701 689 110 1072 415 108 1067 422 149 59 152 56 
H-negative risk:  689 701 1067 1072 422 415 108 110 152 149 56 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
346 
disease_progression 
H-positive risk:  698 688 108 1076 425 104 1068 419 152 55 152 55 
H-negative risk:  688 698 1068 1076 419 425 104 108 152 152 55 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
347 
disease_progression 
H-positive risk:  708 686 107 1069 435 104 1060 415 155 56 149 56 
H-negative risk:  686 708 1060 1069 415 435 104 107 149 155 56 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
348 
disease_progression 
H-positive risk:  715 684 103 1065 434 107 1057 416 152 58 152 57 
H-negative risk:  684 715 1057 1065 416 434 107 103 152 152 57 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
349 
disease_progression 
H-positive risk:  712 687 100 1069 436 107 1052 418 149 59 153 58 
H-negative risk:  687 712 1052 1069 418 436 107 100 153 149 58 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
350 
disease_progression 
H-positive risk:  714 689 100 1067 442 105 1049 420 152 54 153 55 
H-negative risk:  689 714 1049 1067 420 442 105 100 153 152 55 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
351 
disease_progression 
H-positive risk:  710 691 99 1064 438 103 1063 420 151 56 148 57 
H-negative risk:  691 710 1063 1064 420 438 103 99 148 151 57 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
352 
disease_progression 
H-positive risk:  708 687 97 1067 438 105 1071 420 149 55 144 59 
H-negative risk:  687 708 1071 1067 420 438 105 97 144 149 59 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
353 
disease_progression 
H-positive risk:  707 684 97 1073 439 108 1071 414 147 53 146 61 
H-negative risk:  684 707 1071 1073 414 439 108 97 146 147 61 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
354 
disease_progression 
H-positive risk:  711 683 97 1075 440 107 1066 415 143 54 147 62 
H-negative risk:  683 711 1066 1075 415 440 107 97 147 143 62 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
355 
disease_progression 
H-positive risk:  710 689 97 1070 436 110 1071 409 148 51 147 62 
H-negative risk:  689 710 1071 1070 409 436 110 97 147 148 62 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
356 
disease_progression 
H-positive risk:  708 683 97 1076 434 108 1075 410 150 50 150 59 
H-negative risk:  683 708 1075 1076 410 434 108 97 150 150 59 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
357 
disease_progression 
H-positive risk:  710 676 95 1080 437 104 1071 418 148 51 152 58 
H-negative risk:  676 710 1071 1080 418 437 104 95 152 148 58 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
358 
disease_progression 
H-positive risk:  718 676 92 1073 437 105 1079 415 148 47 153 57 
H-negative risk:  676 718 1079 1073 415 437 105 92 153 148 57 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
359 
disease_progression 
H-positive risk:  718 678 94 1071 435 102 1079 411 153 49 153 57 
H-negative risk:  678 718 1079 1071 411 435 102 94 153 153 57 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
360 
disease_progression 
H-positive risk:  721 668 94 1071 442 104 1089 403 153 47 150 58 
H-negative risk:  668 721 1089 1071 403 442 104 94 150 153 58 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
Time difference of 17.00268 mins
This is task 1
